Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Disorder × ruxolitinib × 1 year × Clear all

Sponsor

Conditions

Primary Myelofibrosis 19 Myeloproliferative Disorders 14 Leukemia, Myeloid, Acute 13 Polycythemia Vera 10 Leukemia 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Thrombocythemia, Essential 8 Myelodysplastic Syndromes 7 Recurrence 6 Graft vs Host Disease 6 Myelodysplastic-Myeloproliferative Diseases 4 Lymphoma 4 Prostatic Neoplasms 3 Neoplasms 3 Lymphoma, T-Cell, Cutaneous 3 Lymphoma, T-Cell 3 Lymphoma, Non-Hodgkin 3 Leukemia, Prolymphocytic, T-Cell 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Hematologic Neoplasms 3 Glioblastoma 3 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Triple Negative Breast Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Multiple Myeloma 2 Lymphoma, T-Cell, Peripheral 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid, Chronic-Phase 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡